Results 131 to 140 of about 27,163 (253)

The spingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium [PDF]

open access: yes, 2012
The sphingosine-1-phosphate (S1P) analogue, FTY720, is therapeutically efficacious in multiple sclerosis and in the prevention of transplant rejection.
Hall, Lindsay J.   +7 more
core  

Sequence of cardiovascular autonomic alterations after fingolimod initiation [PDF]

open access: bronze, 2017
Sakari Simula   +4 more
openalex   +1 more source

Investigation of fingolimod-induced lymphocyte sequestration on inflammatory response and neurological damages after cardiac arrest

open access: yesIntensive Care Medicine Experimental
Background A sepsis-like syndrome is known to occur after cardiac arrest, leading to cerebral infiltration by white blood cells (WBC). We hypothesized that pharmacological sequestration of WBC, and more specifically lymphocytes within lymphoid tissues ...
Yara Abi Zeid Daou   +11 more
doaj   +1 more source

Is it time to target no evident disease activity (NEDA) in multiple sclerosis? [PDF]

open access: yes, 2015
Banwell   +25 more
core   +1 more source

Progressive Functional and Neuroretinal Affectation in Patients With Multiple Sclerosis Treated With Fingolimod

open access: green, 2020
Elena García‐Martín   +9 more
openalex   +2 more sources

FINGOLIMOD IN NEWCASTLE: THE FIRST 100 PATIENTS' EXPERIENCE [PDF]

open access: bronze, 2014
Achillefs Spyropoulos   +5 more
openalex   +1 more source

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients [PDF]

open access: gold, 2021
Diana Ferraro   +10 more
openalex   +1 more source

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal [PDF]

open access: gold, 2021
Valeria Koska   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy